Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.56 USD
-0.33 (-1.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.55 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
OSCR 17.56 -0.33(-1.84%)
Will OSCR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OSCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OSCR
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
OSCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
Other News for OSCR
Longleaf Partners Small-Cap Fund Q1 2024 Commentary
Auxa Health secures $5.2 in Funding to Drive Benefit Navigation
Largest borrow rate increases among liquid names
First Week of OSCR June 21st Options Trading
2024 Appian Innovation Award Winners Demonstrate Significant Business Results with Next-Gen AI Process Automation